K

Kynos Therapeutics Ltd.

8 employees

Kynos Therapeutics develops KMO inhibitors across key indications in inflammation, immunity, and metabolism.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Immunometabolism
Health Care
Therapeutics
Oncology
Medical
Inflammation
Drug development

Date founded

2020

Funding rounds raised

Total raised

$8.5M

from 4 investors over 4 rounds

K

Kynos Therapeutics Ltd. raised $8.5M on April 7, 2022

Investors: Epidarex Capital, Scottish Enterprise and IP Group plc

K

Kynos Therapeutics Ltd. raised $3.3M on April 7, 2022

Investors: Innovate UK

FAQ